trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Fan J et al. [Expression of ER alpha in chemically induced MDA-MB-435 cells and its responsiveness to endocrine]. 2006 Zhonghua Zhong Liu Za Zhi pmid:17533736
de Boer J et al. Inhibition of histone acetylation as a tool in bone tissue engineering. 2006 Tissue Eng. pmid:17518660
Takahashi K et al. Homozygous deletion and reduced expression of the DOCK8 gene in human lung cancer. 2006 Int. J. Oncol. pmid:16391785
Topark-Ngarm A et al. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. 2006 J. Biol. Chem. pmid:16950772
Bai T et al. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells. 2006 Int. J. Oncol. pmid:16391806
Li Y et al. A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. 2006 Genes Dev. pmid:16980585
Minetti GC et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. 2006 Nat. Med. pmid:16980968
Ohnishi K [Therapeutic strategies for patients with relapsed acute promyelocytic leukemia]. 2006 Rinsho Ketsueki pmid:16986710
Yang QC et al. Inhibition of hypoxia-induced angiogenesis by trichostatin A via suppression of HIF-1a activity in human osteosarcoma. 2006 J. Exp. Clin. Cancer Res. pmid:17310851
Akiyama T et al. Inadequate histone deacetylation during oocyte meiosis causes aneuploidy and embryo death in mice. 2006 Proc. Natl. Acad. Sci. U.S.A. pmid:16651529
Hernandez M et al. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. 2006 Prostate pmid:16652385
Uchida H et al. Human endometrial cytodifferentiation by histone deacetylase inhibitors. 2006 Hum. Cell pmid:16643606
Stefanovsky V and Moss T Regulation of rRNA synthesis in human and mouse cells is not determined by changes in active gene count. 2006 Cell Cycle pmid:16582637
Wang Q et al. Histone deacetylation is required for orderly meiosis. 2006 Cell Cycle pmid:16582639
Iacomino G et al. Effects of histone deacetylase inhibitors on p55CDC/Cdc20 expression in HT29 cell line. 2006 J. Cell. Biochem. pmid:16795040
Vanniasinkam T et al. Trichostatin-A enhances adaptive immune responses to DNA vaccination. 2006 J. Clin. Virol. pmid:16765083
Li GC et al. Histone deacetylase inhibitor trichostatin A inhibits the growth of bladder cancer cells through induction of p21WAF1 and G1 cell cycle arrest. 2006 Int. J. Urol. pmid:16771729
Zhou C et al. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells. 2006 Int. J. Oncol. pmid:16773209
Zampetaki A et al. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. 2006 Biochem. Biophys. Res. Commun. pmid:16814255
Jüngel A et al. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. 2006 Ann. Rheum. Dis. pmid:16284094
Sestáková B and Vachtenheim J Distinct co-regulation of endogenous versus transfected MITF-dependent tyrosinase promoter. 2006 Folia Biol. (Praha) pmid:17116288
Balasubramaniyan V et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. 2006 Neuroscience pmid:17084985
Zhang Y et al. Phosphatidylinositol 3-kinase/protein kinase Czeta-induced phosphorylation of Sp1 and p107 repressor release have a critical role in histone deacetylase inhibitor-mediated derepression [corrected] of transcription of the luteinizing hormone receptor gene. 2006 Mol. Cell. Biol. pmid:16943418
Yu Z and Kone BC Targeted histone H4 acetylation via phosphoinositide 3-kinase- and p70s6-kinase-dependent pathways inhibits iNOS induction in mesangial cells. 2006 Am. J. Physiol. Renal Physiol. pmid:16174862
Mühlisch J et al. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood. 2006 Oncogene pmid:16186793
He J et al. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219959
Liu H et al. Trichostatin A regulates hGCN5 expression and cell cycle on Daudi cells in vitro. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219960
Sun C et al. Anticancer activities of trichostatin A on maligant lymphoid cells. 2006 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:17219961
Kim HR et al. Trichostatin A induces apoptosis in lung cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway? 2006 Exp. Mol. Med. pmid:17202837
Zhang X et al. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. 2006 Oncol. Rep. pmid:16865256
Villanueva R et al. Histone deacetylase 3 represses HTLV-1 tax transcription. 2006 Oncol. Rep. pmid:16865259
van den Boom J et al. Identification of novel genes associated with astrocytoma progression using suppression subtractive hybridization and real-time reverse transcription-polymerase chain reaction. 2006 Int. J. Cancer pmid:16865689
Bai J et al. Histone deacetylase inhibitor trichostatin A and proteasome inhibitor PS-341 synergistically induce apoptosis in pancreatic cancer cells. 2006 Biochem. Biophys. Res. Commun. pmid:16904634
Charrier C et al. Synthesis of rigid trichostatin A analogs as HDAC inhibitors. 2006 Bioorg. Med. Chem. Lett. pmid:16904890
Kong X et al. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. 2006 Mol. Cell. Biol. pmid:16507982
Araki H et al. Expansion of human umbilical cord blood SCID-repopulating cells using chromatin-modifying agents. 2006 Exp. Hematol. pmid:16459182
Sonnemann J et al. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. 2006 Int. J. Oncol. pmid:16465382
Pedram M et al. Telomere position effect and silencing of transgenes near telomeres in the mouse. 2006 Mol. Cell. Biol. pmid:16479005
Rybouchkin A et al. Role of histone acetylation in reprogramming of somatic nuclei following nuclear transfer. 2006 Biol. Reprod. pmid:16481594
Cecconi D et al. Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A. 2005 Nov-Dec J. Proteome Res. pmid:16335935
Garcia BA et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. 2005 Nov-Dec J. Proteome Res. pmid:16335948
Chen LJ et al. [hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403252
Liu H et al. [Antineoplastic effect of valproic acid and trichostatin on HL-60 and K562 cells]. 2005 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:16403260
Chen J and Kang JH Quercetin and trichostatin A cooperatively kill human leukemia cells. 2005 Pharmazie pmid:16320950
Wei M et al. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. 2005 Cancer Res. pmid:16322213
Chang CW et al. Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. 2005 Mol. Cell. Biol. pmid:16166624
Jori FP et al. RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells. 2005 Cell Death Differ. pmid:15459751
Hammond SM et al. Negative regulatory elements are present in the human LMO2 oncogene and may contribute to its expression in leukemia. 2005 Leuk. Res. pmid:15541480
Fang MZ et al. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. 2005 Clin. Cancer Res. pmid:16203797
García-Morales P et al. Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. 2005 Mol. Cancer Ther. pmid:16093438
Menegola E et al. Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity. 2005 Birth Defects Res. B Dev. Reprod. Toxicol. pmid:16193500
Nome RV et al. Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell death. 2005 Mol. Cancer Ther. pmid:16093439
Liu AL et al. [A new target of cancer therapy: advances in the study of histone deacetylase]. 2005 Yao Xue Xue Bao pmid:16196262
Zhang Y et al. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. 2005 Mol. Cell. Biol. pmid:16135786
Ren C et al. Peptide mass mapping of acetylated isoforms of histone H4 from mouse lymphosarcoma cells treated with histone deacetylase (HDACs) inhibitors. 2005 J. Am. Soc. Mass Spectrom. pmid:16099169
Shinji C et al. Design and synthesis of phthalimide-type histone deacetylase inhibitors. 2005 Bioorg. Med. Chem. Lett. pmid:16137884
Danaher RJ et al. Histone deacetylase inhibitors induce reactivation of herpes simplex virus type 1 in a latency-associated transcript-independent manner in neuronal cells. 2005 J. Neurovirol. pmid:16036811
Laribee RN and Klemsz MJ Histone H4 HDAC activity is necessary for expression of the PU.1 gene. 2005 Biochim. Biophys. Acta pmid:16139904
Blagosklonny MV et al. Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. 2005 Cancer Res. pmid:16103091
Choi JH et al. Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. 2005 Arterioscler. Thromb. Vasc. Biol. pmid:16141407
Krouwels IM et al. A glue for heterochromatin maintenance: stable SUV39H1 binding to heterochromatin is reinforced by the SET domain. 2005 J. Cell Biol. pmid:16103223
Ishihara K [Role of eosinophils in allergic inflammation]. 2005 Yakugaku Zasshi pmid:16141691
Lu Q et al. Structure-based optimization of phenylbutyrate-derived histone deacetylase inhibitors. 2005 J. Med. Chem. pmid:16107152
Yanada M et al. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. 2005 Oncol. Rep. pmid:16142337
Uchida H et al. Histone deacetylase inhibitors induce differentiation of human endometrial adenocarcinoma cells through up-regulation of glycodelin. 2005 Endocrinology pmid:16123169
Su M et al. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells. 2005 J. Biol. Chem. pmid:16087680
Wen J et al. Tal1/SCL binding to pericentromeric DNA represses transcription. 2005 J. Biol. Chem. pmid:15677454
Illi B et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. 2005 Circ. Res. pmid:15705964
Jalonen U et al. Inhibition of tristetraprolin expression by dexamethasone in activated macrophages. 2005 Biochem. Pharmacol. pmid:15710351
Schmittwolf C et al. In vivo haematopoietic activity is induced in neurosphere cells by chromatin-modifying agents. 2005 EMBO J. pmid:15660132
Kang J et al. Antioxidants and trichostatin A synergistically protect against in vitro cytotoxicity of Ni2+ in human hepatoma cells. 2005 Toxicol In Vitro pmid:15649630
Peltonen K et al. Melanoma cell lines are susceptible to histone deacetylase inhibitor TSA provoked cell cycle arrest and apoptosis. 2005 Pigment Cell Res. pmid:15892716
Schwahn DJ et al. Dynamic regulation of the human dopachrome tautomerase promoter by MITF, ER-alpha and chromatin remodelers during proliferation and senescence of human melanocytes. 2005 Pigment Cell Res. pmid:15892717
Tran T et al. Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. 2005 Cancer Res. pmid:15899836
Camelo S et al. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis. 2005 J. Neuroimmunol. pmid:15885809
Young DA et al. Differential effects of histone deacetylase inhibitors on phorbol ester- and TGF-beta1 induced murine tissue inhibitor of metalloproteinases-1 gene expression. 2005 FEBS J. pmid:15819885
Canes D et al. Histone deacetylase inhibitors upregulate plakoglobin expression in bladder carcinoma cells and display antineoplastic activity in vitro and in vivo. 2005 Int. J. Cancer pmid:15499627
Yamaguchi K et al. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. 2005 J. Biol. Chem. pmid:15994313
Zhao XY et al. Granulocyte-macrophage colony-stimulating factor induces de novo methylation of the p15 CpG island in hematopoietic cells. 2005 Cytokine pmid:15996479
Sato N et al. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. 2005 Clin. Cancer Res. pmid:16000561
Munshi A et al. Histone deacetylase inhibitors radiosensitize human melanoma cells by suppressing DNA repair activity. 2005 Clin. Cancer Res. pmid:16000590
Sng JC et al. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. 2005 Neurosci. Lett. pmid:16002216
Sonnemann J et al. Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines. 2005 Invest New Drugs pmid:15744585
Shetty S et al. Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. 2005 Mol. Cell. Biol. pmid:15964798
Place RF et al. HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha. 2005 Biochem. Pharmacol. pmid:15950952
Komata T et al. Histone deacetylase inhibitors, N-butyric acid and trichostatin A, induce caspase-8- but not caspase-9-dependent apoptosis in human malignant glioma cells. 2005 Int. J. Oncol. pmid:15809727
Schroeder TM and Westendorf JJ Histone deacetylase inhibitors promote osteoblast maturation. 2005 J. Bone Miner. Res. pmid:16294278
Endo T et al. Changes in histone modifications during in vitro maturation of porcine oocytes. 2005 Mol. Reprod. Dev. pmid:15736133
Fan S et al. Valproic acid enhances gene expression from viral gene transfer vectors. 2005 J. Virol. Methods pmid:15737413
Bártová E et al. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases. 2005 J. Cell. Sci. pmid:16254244
Xu S et al. Abrogation of DUSP6 by hypermethylation in human pancreatic cancer. 2005 J. Hum. Genet. pmid:15824892
Strait KA et al. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad. 2005 Mol. Cancer Ther. pmid:15827334
McKenzie GJ et al. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. 2005 J. Neurochem. pmid:15773917
Blais M et al. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. 2005 DNA Cell Biol. pmid:15812237
Sato N et al. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma. 2005 Oncogene pmid:15592528
Davidson SM et al. The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin. 2005 Chembiochem pmid:15593114
Maxhimer JB et al. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C). 2005 J. Thorac. Cardiovasc. Surg. pmid:15632825
Kondo T et al. Loss of heterozygosity and histone hypoacetylation of the PINX1 gene are associated with reduced expression in gastric carcinoma. 2005 Oncogene pmid:15637589
Senawong T et al. BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. 2005 Arch. Biochem. Biophys. pmid:15639232
Nambiar MP et al. Transcriptional induction of cholinesterase expression and protection against chemical warfare nerve agents. 2005 Chem. Biol. Interact. pmid:16429504